Search Results - "Kristian, Alexandr"
-
1
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation
Published in Molecular cancer therapeutics (01-06-2011)“…In many types of cancer, the expression of the immunoregulatory protein B7-H3 has been associated with poor prognosis. Previously, we observed a link between…”
Get full text
Journal Article -
2
Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist
Published in Cancer imaging (19-12-2019)“…Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) may be used to depict tumour vascular structure and for therapy response assessment in various…”
Get full text
Journal Article -
3
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
Published in Proceedings of the National Academy of Sciences - PNAS (09-07-2013)“…The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major…”
Get full text
Journal Article -
4
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Published in Molecular oncology (01-10-2023)“…Liver X receptors (LXRs) are nuclear transcription factors important in the regulation of cholesterol transport, and glucose and fatty acid metabolism. The…”
Get full text
Journal Article -
5
Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations
Published in Clinical cancer research (15-01-2014)“…Neoangiogenesis is an important feature in tumor growth and progression, and combining chemotherapy and antiangiogenic drugs have shown clinical efficacy…”
Get full text
Journal Article -
6
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma
Published in PloS one (20-05-2010)“…Malignant melanoma is an exceptionally aggressive, drug-resistant and heterogeneous cancer. Recently it has been shown that melanoma cells with high clonogenic…”
Get full text
Journal Article -
7
STAMP2 increases oxidative stress and is critical for prostate cancer
Published in EMBO molecular medicine (01-03-2015)“…The six transmembrane protein of prostate 2 ( STAMP2) is an androgen‐regulated gene whose mRNA expression is increased in prostate cancer (PCa). Here, we show…”
Get full text
Journal Article -
8
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Published in Breast cancer research : BCR (28-02-2013)“…The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in cancer cells through numerous mutations and epigenetic changes. The recent…”
Get full text
Journal Article -
9
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
Published in International journal of cancer (01-08-2011)“…E7080 is an inhibitor of multiple tyrosine kinases, several of which have pro‐angiogenic properties, including receptors for VEGF, FGF, SCF and PDGF. We…”
Get full text
Journal Article -
10
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft
Published in PloS one (24-11-2014)“…Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge…”
Get full text
Journal Article -
11
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
Published in Radiation oncology (London, England) (27-09-2012)“…The histone deacetylase inhibitor vorinostat is a candidate radiosensitizer in locally advanced rectal cancer (LARC). Radiosensitivity is critically influenced…”
Get full text
Journal Article -
12
Exploring the peritoneal surface malignancy phenotype—a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
Published in Human pathology (01-08-2010)“…Summary Peritoneal surface malignancies are characterized by the propensity for tumor growth on peritoneal surfaces without development of extraperitoneal…”
Get full text
Journal Article -
13
Longitudinal Magnetic Resonance Imaging-Based Assessment of Vascular Changes and Radiation Response in Androgen-Sensitive Prostate Carcinoma Xenografts under Androgen-Exposed and Androgen-Deprived Conditions
Published in Neoplasia (New York, N.Y.) (01-10-2010)“…Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. However, complete eradication of PCa is unusual, and…”
Get full text
Journal Article -
14
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
Published in BMC cancer (01-09-2010)“…Mitomycin C is a chemotherapeutic agent used in the treatment of peritoneal surface malignancies, administered as hyperthermic intraperitoneal chemotherapy…”
Get full text
Journal Article -
15
Dynamic 18F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
Published in Nuclear medicine and molecular imaging (01-09-2013)“…Purpose To compare dynamic 2-deoxy-2-[18F]fluoro-Dglucose positron emission tomography (18F-FDG PET) parameters in two selected human breast cancer xenografts…”
Get full text
Journal Article -
16
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Published in British journal of cancer (10-10-2024)“…Background Resistance to chemotherapy, combined with heterogeneity among resistant tumors, represents a significant challenge in the clinical management of…”
Get full text
Journal Article -
17
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Published in Molecular oncology (2023)“…Liver X receptors (LXRs) are nuclear transcription factors important in the regulation of cholesterol transport, and glucose and fatty acid metabolism. The…”
Get full text
Journal Article -
18
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
Published in Acta oncologica (01-10-2013)“…Dynamic (18)F-FDG PET allows the study of glucose distribution in tissues as a function of time and space. Using pharmacokinetics, the temporal uptake pattern…”
Get more information
Journal Article -
19
Variability of dynamic 18F-FDG-PET data in breast cancer xenografts
Published in Acta oncologica (21-10-2015)“…A murine breast cancer xenograft model was employed to evaluate inter- and intra-variability of various parameters derived from dynamic positron emission…”
Get more information
Journal Article -
20
Abstract 2053: Dynamic 18F-FDG PET parameters variation in patient-derived breast cancer xenograft and correlation with outcome following treatment with cytotoxic agents
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Using pharmacokinetic modeling for dynamic 18FDG PET (D-PET) the temporal and spatial uptake pattern of 18FDG may be separated into components…”
Get full text
Journal Article